The present invention relates to magnetic resonance imaging (MRI) and more specifically to techniques for imaging tissue stiffness and blood flow simultaneously.
Changes in hemodynamics (e.g., blood flow) and viscoelasticity (e.g., tissue stiffness) have been linked to a wide range of cardiovascular conditions, and the measurement of each may provide complementary information that can elucidate complex disease mechanisms and/or improve diagnosis. For example, in patients with aortic aneurysm or valvular disease, hemodynamics may quantify a wall shear stress exerted by blood on a diseased section of the organ, and tissue stiffness may provide the ability of the organ to comply with the wall shear stress. As a result, the collective information from hemodynamics and tissue stiffness can potentially yield a more comprehensive biomarker for diagnosis and prognosis of complex diseases.
While phase-contrast magnetic resonance imaging (PC-MRI) has been used to examine blood flow and tissue stiffness, it is generally not feasible, in clinical settings, to image both using a single scan acquisition for a variety of reasons. First, the acquisition time (i.e., scan time) necessary to acquire two datasets, one for blood-flow imaging and one for tissue-stiffness imaging, is extremely long. Second, patients are typically unable to sustain the multiple, long breath-holds necessary for two acquisitions. Third, variation in breath-holds from one scan to another may cause a registration mismatch between the resulting images. This variation between datasets makes interpretation difficult, which may lead to a misdiagnosis.
A need, therefore, exists for acquisition and processing methods to image blood flow and tissue stiffness from a single dataset (i.e., from a single acquisition). Use of these methods may offer a plurality of advantages, including, but not limited to (i) reduced scan time, (ii) automatic registration of datasets, (iii) reduced susceptibility to physiological changes, (iv) eased breath-hold requirements, and (v) complementary information for improved understanding/diagnosis.
Accordingly, a first data acquisition method disclosed herein embraces encoding both tissue motion and fluid flow in a magnetic resonance imaging (MRI) acquisition. For this simultaneous encoding, a combined gradient (CG) waveform is created that is a weighted combination of a motion encoding gradient (MEG) waveform and a velocity encoding gradient (VEG) waveform. During the MRI acquisition, an oscillatory motion is applied to a tissue of interest located within the MRI field of view. The oscillatory motion creates shear waves in the tissue. Also during the MRI acquisition, the CG waveform is applied to one or more gradients in a pulse sequence. The MEG component of the CG waveform encodes the shear waves into the phase of the spins in the tissue, while the VEG component of the CG waveform encodes the fluid flow into the phase of spins in the tissue.
In accordance with an aspect of the first method, the pulse sequence may be a spin-echo (SE) or a gradient recalled echo (GRE) pulse sequence, and in these cases the CG waveform is be applied to one or more gradients after a 90 degree radio frequency (RF) pulse and before a readout gradient.
In accordance with another aspect of the first method, the one or more gradients may include the slice-select gradient, the frequency encode gradient, and the phase-encode gradient, and the one or more gradients may be aligned with the direction of the shear wave's propagation and/or the direction of the fluid flow.
In accordance with another aspect of the first method, the MEG waveform, such as a W1-2-1 waveform used in magnetic resonance elastography (MRE), has a nonzero inner product with the gradient waveform and the oscillation. In some cases, the W1-2-1 waveform may be adjusted to match the frequency of the oscillatory motion. In other cases, the W1-2-1 waveform may be adjusted to mismatch the frequency of the oscillatory motion. In still other cases, the oscillatory motion may be adjusted to have a particular phase offset with the W1-2-1 waveform.
In accordance with another aspect of the first method, the VEG waveform, such as a W1-1 waveform used in magnetic resonance velocity imaging, has a non-zero first moment.
In accordance with another aspect of the first method, the application of the CG waveform to a gradient during a pulse sequence for an MRI acquisition creates an accumulation of phase in the spins that corresponds to both (i) tissue displacement caused by the shear waves and (ii) fluid-flow velocity.
In accordance with another aspect of the first method, the CG waveform may be calculated using the equation
CG=(1−k1)×W1-2-1+k1×W1-1,
wherein CG is the combined waveform, W1-2-1 is a repeating-bipolar waveform used in magnetic resonance elastography (MRE), W1-1 is a nonrepeating-bipolar waveform used in magnetic resonance velocity imaging, and k1 is a constant that is adjustable from zero to one. In some cases, k1 may be adjusted so, during the MRI acquisition, the accumulation of the spin phase resulting from tissue displacement and the accumulation of spin phase resulting from fluid-flow velocity are approximately equal.
In general, W1-2-1 may be a waveform in which the inner product between the waveform and the sinusoidal oscillation of spins in space is large in comparison to the waveform's first moment. Additionally, W1-1 may a waveform in which the inner product between the waveform and the sinusoidal oscillation of spins in space is small in comparison to the waveform's first moment.
Additionally, the first method may further include the steps of (i) phase shifting the applied oscillatory motion to create a phase offset between the MEG waveform (e.g., the MEG component of the CG waveform) and the oscillatory motion and (ii) applying the CG waveform to one or more gradients in a pulse sequence for a subsequent MRI acquisition. Then, repeating these steps using different offsets to sample the shear waves as they propagate through the tissue.
The entire coding process may then repeated with the reverse polarity of CG (−1×CG) to create two datasets for each phase offset. Through this, the background phase may be diminished through a conjugate multiplication of the positive CG dataset and the negative CG dataset, and a phase map for each offset may be created.
The first method's simultaneous acquisition of a tissue stiffness map and a blood flow map from a single MRI scan requires less time than would be obtained by separately acquiring a tissue stiffness map from a first MRI scan and a blood flow map from a second MRI scan.
A second data processing method is also disclosed herein. The second method embraces extracting (i) a tissue stiffness map and (ii) a blood flow map, both from the phase maps extracted in the first method. The resulting phase images are then transformed using a Fourier transform applied along the offsets. The transformation decouples the information into baseband, first, and second harmonics of the frequency of the oscillatory motion. The flow-related phase energy is grouped around a baseband and the external oscillatory wave frequency related phase energy is grouped around the first harmonic. The first-harmonic information is used to create the map of tissue stiffness in the subject, while the baseband information is used to create the map of blood flow in the subject.
The foregoing illustrative summary, as well as other exemplary objectives and/or advantages, and the manner in which the same are accomplished, are further explained within the following detailed description and its accompanying drawings.
MRE and velocity imaging are phase-contrast based techniques used in MRI to quantify tissue stiffness and flow velocity, respectively. Both techniques use special encoding waveforms applied to gradients during an MRI pulse sequence (e.g., spin echo, gradient recalled echo, etc.).
An exemplary gradient-recalled echo (GRE) pulse sequence 100 is shown in
In velocity (i.e., flow) imaging, the spins are additionally phase encoded so that the spin phases also correspond to the velocity of fluid (e.g., blood, spinal fluid, etc.) flow. To achieve this, a velocity encoding gradient (VEG) waveform 200 is applied to one or more of the gradients during the pulse sequence. Typically, bipolar gradients are preferred for flow imaging due to their high first moment (M1). Phase accumulation occurs when a spin experiences a VEG gradient waveform with a non-zero (e.g., high) M1. Mathematically, the phase accumulation is given by:
γv∫0TEGt dt,
where γ is the gyromagnetic ratio, v is the velocity of the spin, t is time, ∫0TE Gt is first moment, and TE is the echo time (i.e., the time between the 90 degree RF pulse and readout). A typical VEG waveform 200 is shown in
A GRE pulse sequence 100 with a VEG waveform 200 applied to a gradient (Gφ) is shown in
In MR elastography, the spins are phase encoded so that the spin phases correspond to the motion of tissue (i.e., shear waves) caused by applying a mechanical vibration to the subject during scan. To achieve this, a motion encoding gradient (MEG) waveform is applied to one or more of the gradients during the pulse sequence. Typically, repeating W1-2-1 gradients are preferred for MRE imaging due to their low first moment (M1) and hence insensitivity to flow. Phase accumulation occurs when the MEG waveform is synchronized with the mechanical motion (i.e., oscillatory motion) applied to the tissues of a subject during the scan. Mathematically, the magnitude of phase accumulation is given by:
0.5γNT<G,ξ>,
where N is the number of gradient cycles, G is the encoding gradient waveform, ξ is the sinusoidal oscillation of spin in space, T is the period of waveform, and <, > is the inner product. A MEG waveform 400 is shown in
A GRE pulse sequence 100 with a MEG waveform 400 applied to a gradient (Gφ) is shown in
Typically, MRE and velocity imaging are performed as separate scans. The present disclosure embraces a co-imaging technique that utilizes a combined gradient (CG) waveform suitable for encoding both velocity and motion. The CG waveform offers a trade-off between <G, ξ> and ∫0TEGt dt. The CG waveform may be customized to control the sensitivity (i.e., phase accumulation) of MRE-related oscillation and the velocity. As an example, varying k1 in the CG waveform,
CG=(1−k1)×W1-2-1+k1×W1-1,
offers a sensitivity tradeoff.
The choice of k1 is made to insure that both phenomena can be detected in the resulting MRI images (e.g., phase images). As highlighted 700 in the exemplary graph shown in
As shown in
A co-imaging MRI acquisition method 900 is illustrated in the flow diagram shown in
The phase offset between the CG waveform and the oscillatory motion may be repeatedly adjusted (e.g., for a number, N, of offsets) 905 to obtain additional phase maps for different phase offsets.
Data processing techniques are used to separate the phase contributions from MRE and velocity. To delineate phase encoded for MRE and velocity, a Fourier transform may be computed along the offset dimension 906 (i.e., along the temporal evaluation of the shear wave). The Fourier transform will result in signals generally organized into different harmonics.
The signal from MRE may be grouped about the first harmonic (i.e., 1x) of the oscillatory signal applied to the tissues of a subject; while the signal from flow may be grouped about the 0th harmonic (i.e., baseband) since the phase due to flow is not modulated by an external mechanical stimulus. Because of the separation in frequency (i.e., Fourier domain), the two signals may be separated (e.g., by filtering) 907. After separating the two signals, the two resulting signals can be processed using known MRI methods to obtain a flow image 908 and a tissue stiffness map 909.
As compared to conventional flow imaging, the techniques described here (i.e., “elastoflow” imaging) may be used to obtain images with improved (i.e., increased) signal-to-noise ratios.
In the specification and/or figures, typical embodiments of the invention have been disclosed. The present invention is not limited to such exemplary embodiments. The use of the term “and/or” includes any and all combinations of one or more of the associated listed items. The figures are schematic representations and so are not necessarily drawn to scale. Unless otherwise noted, specific terms have been used in a generic and descriptive sense and not for purposes of limitation.
This non-provisional application claims the benefit of U.S. Provisional Application No. 62/338,729, filed May 19, 2016, the whole disclosure of which is incorporated by reference herein.
The present application was made with government support under R01HL24096 awarded by the National Institute of Health and under 13SDG14690027 awarded by the American Heart Association. The government has certain rights in the invention.
Number | Date | Country | |
---|---|---|---|
62338729 | May 2016 | US |